Last reviewed · How we verify
INULIN
At a glance
| Generic name | INULIN |
|---|---|
| Sponsor | Iso Tex |
| Drug class | Non-Standardized Food Allergenic Extract [EPC] |
| Therapeutic area | Nephrology |
| Phase | FDA-approved |
| First approval | 1940 |
Approved indications
- Renal function study
Common side effects
Key clinical trials
- Prebiotics, Gut Microbiota, and Cardiometabolic Health (NA)
- Evaluation of the Hepatoprotective Effects of a Nutritional Supplement in Patients With Liver Disease Secondary to Chronic Hepatitis C Virus Infection (RESQUETI Study). (NA)
- Impact Of The Gut Microbiota On Host Cells Energy Metabolism in Health And In Inflammatory Bowel Disease (PHASE2)
- Impact of Supplementation With Synbiotics and Prebiotics on Cognitive Decline Associated With Neoadjuvant Chemotherapy in First-line Patients With Breast Cancer (NA)
- A Clinical Trial of Soluble Fiber for Asthma (PHASE2)
- Synbiotics in Patients at RIsk fOr Preterm Birth (NA)
- The Efficacy and Safty of FMT in Patients With CID (PHASE1,PHASE2)
- Validation of a Novel Functional Food Designed to Meet the Nutritional Needs of People Living With Parkinson's Disease (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| FDA label | Mechanism, indications, dosing, boxed warnings, drug interactions |
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- INULIN CI brief — competitive landscape report
- INULIN updates RSS · CI watch RSS
- Iso Tex portfolio CI